The Expanding GLP-1 Market

The GLP-1 medication market has expanded rapidly with multiple options now available. While Wegovy, Ozempic, and Mounjaro all target weight loss, they differ significantly in formulation, dosing, indication, and effectiveness.

Wegovy (Semaglutide 2.4mg)

• Indication: Marketed exclusively for weight loss
• Maximum Dose: 2.4mg weekly
• Titration: 16-week gradual increase from 0.25mg
• Average Weight Loss: 15-22% of body weight
• Formulation: Pre-filled pen injector (easy self-administration)
• Dosing Frequency: Once weekly subcutaneous injection

Ozempic (Semaglutide 2mg max)

• Indication: Approved for type 2 diabetes management
• Off-Label Use: Weight loss (common but not FDA-approved indication)
• Maximum Dose: 2mg weekly (lower than Wegovy)
• Average Weight Loss: 5-10% in diabetic patients (less than Wegovy)
• Consideration: Using Ozempic for weight loss is off-label use

Mounjaro (Tirzepatide)

• Status: Newer medication (FDA approved 2022)
• Mechanism: Dual GLP-1 and GIP receptor agonist (two receptors vs. one)
• Dosing: Initial 2.5mg weekly, titrated to maximum 15mg
• Average Weight Loss: 20-25% of body weight (potentially greater than Wegovy)
• Primary Indication: Type 2 diabetes (weight loss indication emerging)

Head-to-Head Comparison Table

Medication | Indication | Max Dose | Avg Weight Loss | Dosing Frequency | Cost Efficiency

Wegovy | Weight loss (specific) | 2.4mg | 15-22% | Once weekly | Moderate

Ozempic | Diabetes (off-label weight loss) | 2.0mg | 5-10% | Once weekly | Lower

Mounjaro | Diabetes (emerging weight loss) | 15mg | 20-25% | Once weekly | Higher

Which Medication Is Right for You?

Wegovy is specifically designed and rigorously tested for weight loss in non-diabetic patients, making it the preferred first-line agent for pure weight loss goals. Mounjaro may offer slightly greater weight loss benefits but is primarily indicated for diabetes management. Your healthcare provider will recommend the optimal choice based on your medical history, current health conditions, and individual health goals.